Michael Fitzgerald

9.2k total citations
107 papers, 4.0k citations indexed

About

Michael Fitzgerald is a scholar working on Cognitive Neuroscience, Psychiatry and Mental health and Clinical Psychology. According to data from OpenAlex, Michael Fitzgerald has authored 107 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Cognitive Neuroscience, 45 papers in Psychiatry and Mental health and 20 papers in Clinical Psychology. Recurrent topics in Michael Fitzgerald's work include Attention Deficit Hyperactivity Disorder (39 papers), Autism Spectrum Disorder Research (38 papers) and Neurotransmitter Receptor Influence on Behavior (14 papers). Michael Fitzgerald is often cited by papers focused on Attention Deficit Hyperactivity Disorder (39 papers), Autism Spectrum Disorder Research (38 papers) and Neurotransmitter Receptor Influence on Behavior (14 papers). Michael Fitzgerald collaborates with scholars based in Ireland, United States and United Kingdom. Michael Fitzgerald's co-authors include Michael Gill, Ziarih Hawi, G Daly, Aiveen Kirley, Naomi Lowe, Sarah E. Heron, Louise Gallagher, M. N. Gooseff, Kamini Singha and Celine Mullins and has published in prestigious journals such as American Journal of Psychiatry, Water Resources Research and Journal of Hydrology.

In The Last Decade

Michael Fitzgerald

103 papers receiving 3.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Fitzgerald Ireland 33 2.1k 2.1k 930 794 604 107 4.0k
Patrick Johnston Australia 39 2.6k 1.2× 817 0.4× 472 0.5× 207 0.3× 555 0.9× 133 4.3k
Heidi Aase Norway 36 1.6k 0.7× 2.3k 1.1× 177 0.2× 722 0.9× 632 1.0× 98 4.7k
Martin H. Schmidt Germany 43 880 0.4× 1.8k 0.9× 602 0.6× 360 0.5× 1.6k 2.6× 167 5.9k
Joanne Rovet Canada 49 782 0.4× 482 0.2× 1.5k 1.6× 246 0.3× 618 1.0× 159 8.5k
G. Robert DeLong United States 33 1.5k 0.7× 865 0.4× 1.1k 1.2× 443 0.6× 441 0.7× 59 3.8k
Paul Arnold Canada 36 2.1k 1.0× 1.0k 0.5× 411 0.4× 808 1.0× 2.3k 3.9× 190 5.3k
Megan M. Herting United States 36 1.7k 0.8× 560 0.3× 157 0.2× 248 0.3× 706 1.2× 99 4.5k
Brion S. Maher United States 36 551 0.3× 678 0.3× 1.5k 1.6× 392 0.5× 722 1.2× 140 4.8k
Heather E. Volk United States 27 1.4k 0.7× 1.1k 0.5× 555 0.6× 76 0.1× 635 1.1× 88 3.5k
Molly Malone Canada 31 1.1k 0.5× 1.7k 0.8× 380 0.4× 613 0.8× 280 0.5× 72 2.4k

Countries citing papers authored by Michael Fitzgerald

Since Specialization
Citations

This map shows the geographic impact of Michael Fitzgerald's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Fitzgerald with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Fitzgerald more than expected).

Fields of papers citing papers by Michael Fitzgerald

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Fitzgerald. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Fitzgerald. The network helps show where Michael Fitzgerald may publish in the future.

Co-authorship network of co-authors of Michael Fitzgerald

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Fitzgerald. A scholar is included among the top collaborators of Michael Fitzgerald based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Fitzgerald. Michael Fitzgerald is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Caci, Hervé, Philip Asherson, Renato Donfrancesco, et al.. (2014). Daily life impairments associated with childhood/adolescent attention-deficit/hyperactivity disorder as recalled by adults: results from the European Lifetime Impairment Survey. CNS Spectrums. 20(2). 112–121. 21 indexed citations
2.
Johnson, Katherine A., Edwina Barry, David Lambert, et al.. (2013). Methylphenidate Side Effect Profile Is Influenced by Genetic Variation in the Attention-Deficit/Hyperactivity Disorder-Associated CES1 Gene. Journal of Child and Adolescent Psychopharmacology. 23(10). 655–664. 26 indexed citations
3.
Fitzgerald, Michael. (2008). Adult deficit hyperactivity disorder and other diagnosis. Irish Journal of Psychological Medicine. 25(4). 160–160. 1 indexed citations
4.
Fitzgerald, Michael. (2007). Autism spectrum disorders: identification, education and treatment, Zager. 3rd Ed. Lawrence Erlbaum: New Jersey, 2003.. Irish Journal of Psychological Medicine. 24(4). 164–164. 5 indexed citations
5.
Domschke, Katharina, Karen Sheehan, Naomi Lowe, et al.. (2005). Association analysis of the monoamine oxidase A and B genes with attention deficit hyperactivity disorder (ADHD) in an Irish sample: Preferential transmission of the MAO‐A 941G allele to affected children. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 134B(1). 110–114. 63 indexed citations
6.
Bellgrove, Mark A., Ziarih Hawi, Aiveen Kirley, et al.. (2005). Association between Dopamine Transporter (DAT1) Genotype, Left-Sided Inattention, and an Enhanced Response to Methylphenidate in Attention-Deficit Hyperactivity Disorder. Neuropsychopharmacology. 30(12). 2290–2297. 77 indexed citations
7.
Fitzgerald, Michael, et al.. (2004). Did Michelangelo (1475–1564) have High-Functioning Autism?. Journal of Medical Biography. 12(2). 115–120. 7 indexed citations
8.
Kirley, Aiveen, Naomi Lowe, Celine Mullins, et al.. (2004). Phenotype studies of the DRD4 gene polymorphisms in ADHD: Association with oppositional defiant disorder and positive family history. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 131B(1). 38–42. 58 indexed citations
9.
Kirley, Aiveen, Naomi Lowe, Ziarih Hawi, et al.. (2003). Association of the 480 bp DAT1 allele with methylphenidate response in a sample of Irish children with ADHD. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 121B(1). 50–54. 121 indexed citations
10.
Gallagher, Louise, et al.. (2003). No association between allelic variants of HOXA1/HOXB1 and autism. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 124B(1). 64–67. 16 indexed citations
11.
Holmes, Jane, Antony Payton, Jennifer H. Barrett, et al.. (2002). Association of DRD4 in children with ADHD and comorbid conduct problems. American Journal of Medical Genetics. 114(2). 150–153. 80 indexed citations
12.
Brophy, K, Ziarih Hawi, Aiveen Kirley, Michael Fitzgerald, & Michael Gill. (2002). Synaptosomal-associated protein 25 (SNAP-25) and attention deficit hyperactivity disorder (ADHD): evidence of linkage and association in the Irish population. Molecular Psychiatry. 7(8). 913–917. 114 indexed citations
13.
Hawi, Ziarih, Debra L. Foley, Aiveen Kirley, et al.. (2001). Dopa decarboxylase gene polymorphisms and attention deficit hyperactivity disorder (ADHD): no evidence for association in the Irish population. Molecular Psychiatry. 6(4). 420–424. 32 indexed citations
14.
Silverman, Jeremy M., Christopher J. Smith, James Schmeidler, et al.. (2001). Symptom domains in autism and related conditions: Evidence for familiality. American Journal of Medical Genetics. 114(1). 64–73. 98 indexed citations
15.
Kent, Lindsey, Elaine Green, Jane Holmes, et al.. (2001). No association between CHRNA7 microsatellite markers and attention‐deficit hyperactivity disorder. American Journal of Medical Genetics. 105(8). 686–689. 21 indexed citations
16.
Fitzgerald, Michael. (2001). Psychopharmacological treatment of adolescent and adult attention deficit hyperactivity disorder. Irish Journal of Psychological Medicine. 18(3). 93–98. 7 indexed citations
17.
Healy, Elaine & Michael Fitzgerald. (2000). A 16-year follow-up of a child inpatient population. European Child & Adolescent Psychiatry. 9(1). 46–53. 10 indexed citations
18.
Hawi, Ziarih, et al.. (2000). No association between catechol-O-methyltransferase (COMT) gene polymorphism and attention deficit hyperactivity disorder (ADHD) in an Irish sample. American Journal of Medical Genetics. 96(3). 282–284. 49 indexed citations
19.
Daly, G, Ziarih Hawi, Michael Fitzgerald, & Michael Gill. (1998). Attention deficit hyperactivity disorder: Association with the dopamine transporter (DAT1) but not with the dopamine D4 receptor (DRD4). American Journal of Medical Genetics Part A. 81(6). 8 indexed citations
20.
Brogdon, B. G., et al.. (1995). Intrathoracic fracture-dislocation of the humerus. Skeletal Radiology. 24(5). 383–5. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026